Logo: to the web site of Uppsala University

uu.sePublications from Uppsala University
Change search
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf
Endograft Infections After Complex Endovascular Aortic Repair
(English)Manuscript (preprint) (Other academic)
Abstract [en]

Background: Aortic endograft infection (AeGI) is a rare but severe complication following complex endovascular aortic repair (cEVAR). Data on its true incidence, risk factors, clinical course, and outcomes is limited to very small case series. This study aimed to determine the incidence and risk factors for AeGI after cEVAR and to describe treatment strategies and outcomes in a complex aortic high-volume center.

Methods: All patients undergoing cEVAR with fenestrated or branched endografts at Uppsala University Hospital, Sweden, between September 2010 and May 2024 were retrospectively identified. Data were crosschecked with the Swedish vascular registry (Swedvasc). AeGI was defined according to the Management of Aortic Graft Infection Collaboration (MAGIC) criteria. Risk factors were assessed using multivariable Cox regression. Outcomes including incidence, microbiology, treatment strategies, survival, and long-term infection status were assessed.

Results: Among 527 patients (542 cEVARs, median follow-up 47.4 months), 19 (3.6%; 723/100 000 patient-years) developed MAGIC-diagnosed AeGI. Independent risk factors to develop complex AeGI was infected native aortic aneurysm (INAA) as index pathology (HR 10.2, CI95: 3.13–33.2) and late aortic-related reinterventions (HR 2.98, CI95: 1.1–7.9). Median time from primary cEVAR to AeGI diagnosis was 10.6 months (IQR: 6.12-31.0 months). Six patients (32%) had a secondary fistula/erosion, associated with poor median survival (fistula: 4.0 months vs. no fistula: 41.5 months). Treatment strategies were almost exclusively graft-persevering; antimicrobial therapy alone 11/19 (58%) or combined with image-guided drainage and/or surgical debridement 7/19 (37%). At last follow-up, remission was achieved in 50%, and treatment failure in 44%, mainly due to AeGI-related mortality.

Conclusion: AeGI after cEVAR is more common than previously reported. Risk is further increased by INAA as index pathology and late aortic reinterventions. Prognosis is poor in patients with secondary fistula, while conservative graft-preserving strategies may achieve durable infectious remission and survival in selected patients.

National Category
Surgery
Identifiers
URN: urn:nbn:se:uu:diva-577023OAI: oai:DiVA.org:uu-577023DiVA, id: diva2:2030221
Available from: 2026-01-20 Created: 2026-01-20 Last updated: 2026-02-22
In thesis
1. On Complications After Aortic Surgery: With A Focus On Aortic Graft and Endograft Infections
Open this publication in new window or tab >>On Complications After Aortic Surgery: With A Focus On Aortic Graft and Endograft Infections
2026 (English)Doctoral thesis, comprehensive summary (Other academic)
Abstract [en]

Aortic surgery has transformed with the widespread adoption of endovascular repair, reducing perioperative morbidity and mortality, particularly in older and frail patients, but introducing new complications and long-term challenges. This thesis investigated outcomes following complications of aortic surgery, focusing on critical care requirements after abdominal aortic aneurysm (AAA) repair and the epidemiology, management, and outcomes of aortic graft and endograft infections (AGI).

Study I analysed a single-centre retrospective cohort of 707 AAA repairs between 1999 and 2013. Prolonged intensive care unit length of stay (ICU LOS) decreased over time while the frequency of endovascular repair increased. Open repair and rupture were the strongest predictors of prolonged ICU stay. Prolonged ICU LOS  was associated with increased short-term mortality, but long-term survival among 90-day survivors was comparable.

Study II compared extra-anatomical bypass (EAB) and in situ reconstruction (ISR) following radical surgical treatment of abdominal AGI in a nationwide Swedish cohort of 126 patients between 1995 and 2017. No differences were observed in short- or long-term survival or reinfection rates between EAB and ISR. Prolonged antimicrobial therapy (>3 months) was independently associated with improved long-term survival.

Study III evaluated semi-conservative (SC) strategies versus radical surgery (RS) for abdominal AGI in 169 patients in the same nationwide cohort. Short-term survival was similar between groups, but SC was associated with a higher risk of recurrent infection, particularly in graft-enteric fistulae. Differences in long-term survival were attenuated after adjustment for comorbidities.

Study IV analysed aortic endograft infections (AeGI) after complex endovascular aortic repair (cEVAR) between 2010 and 2024 in a single center setting. AeGI incidence was higher than after standard EVAR. Infectious index pathology and late aortic reinterventions were independently associated with AeGI. Outcomes were acceptable without secondary fistulae but poor when fistulae were present.

In conclusion, while endovascular repair has reduced early postoperative complications and critical care requirement after aortic surgery, AGI remains a major challenge. AGI outcomes in the studied cohorts were driven less by surgical techniques alone and more by patient and anatomical factors, underscoring the need for individualised, multidisciplinary decision-making.

Place, publisher, year, edition, pages
Uppsala: Acta Universitatis Upsaliensis, 2026. p. 122
Series
Digital Comprehensive Summaries of Uppsala Dissertations from the Faculty of Medicine, ISSN 1651-6206 ; 2236
Keywords
Aorta, Complications, Graft infection, aortic graft infection, endograft infection, vascular prosthetic infection
National Category
Surgery
Research subject
Medical Science
Identifiers
urn:nbn:se:uu:diva-580186 (URN)978-91-513-2753-2 (ISBN)
Public defence
2026-04-10, H:SON HOLMDAHLSALEN, Dag Hammarskjölds väg 8, Akademiska Sjukhuset, Uppsala, 13:00 (English)
Opponent
Supervisors
Available from: 2026-03-18 Created: 2026-02-22 Last updated: 2026-04-08

Open Access in DiVA

No full text in DiVA

Search in DiVA

By author/editor
Gavali, Hamid
Surgery

Search outside of DiVA

GoogleGoogle Scholar

urn-nbn

Altmetric score

urn-nbn
Total: 16 hits
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf